-
-
-
-
- Overview of practice standards
- About the Practice Standards Scheme
- Which accreditation is right for your practice and how to apply
- What happens during an assessment?
- About Stanley, our support system for the PSS
- How do I update my accredited-practice information?
- How can I promote my RCVS accreditation?
- Additional resources
-
- Coronavirus (Covid-19)
- Contact the Advice Team
- Code of Professional Conduct for Veterinary Surgeons
- Code of Professional Conduct for Veterinary Nurses
- GDPR – RCVS information and Q&As
- Advice on Schedule 3
- FAQs – Common medicines pitfalls
- FAQs – Routine veterinary practice and clinical veterinary research
- Dealing with Difficult Situations webinar recordings
-
Prof Elizabeth Simpson
BA VetMB FMedSci FRS HonFRCVS HonDSc
OBE
HonFRCVS
- Location: London
- Route to Fellowship: Honorary Fellowship by election
Field of work
Research institutes
Areas of special interest
- immunogenetics
- infections & immunity
- epidemiology
Areas of support
- International issues
- One Health Agenda
- Professional mentoring
Awards
- FMedSci, FRS, OBE, honFRCVS, honDSc
Biography
Elizabeth Simpson qualified in veterinary medicine in Cambridge.
She set up and ran a mixed practice in New Brunswick, Canada for two years before taking postgraduate pathology training in Cambridge, UK. Becoming interested in the parallels between inflammatory responses to tumours and transplants in animals and humans, she moved into biomedical research at the MRC’s National Institute for Medical Research, London, and contributed to the rapidly growing field of cellular immunology, later, after holding research fellowships in the USA, adding the tools of genetics and molecular biology to probe in vivo and in vitro function.
Recruited back to the UK to head a research team in Transplantation Biology at the MRC’s Clinical Research Centre, Harrow, she included the talents of medical, veterinary and basic science graduates to characterise the molecular identity of target antigens eliciting immune responses to transplants, tumours and autoantigens, and the immune response genes controlling those in vivo manifestations.
Peer review work included membership/chairmanship of MRC, BBSCR, WT, CRUK and ERC research funding committees, and of Scientific Advisory Boards to UK, French, German, Italian and South Korean research institutes.
She was elected a Fellow of the Academy of Medical Sciences in 1999, Fellow of the Royal Society in 2010 and awarded an OBE in 2000, honorary Fellowship of the RCVS in 2010 and an honorary DSc from Imperial in 2015.
She set up and ran a mixed practice in New Brunswick, Canada for two years before taking postgraduate pathology training in Cambridge, UK. Becoming interested in the parallels between inflammatory responses to tumours and transplants in animals and humans, she moved into biomedical research at the MRC’s National Institute for Medical Research, London, and contributed to the rapidly growing field of cellular immunology, later, after holding research fellowships in the USA, adding the tools of genetics and molecular biology to probe in vivo and in vitro function.
Recruited back to the UK to head a research team in Transplantation Biology at the MRC’s Clinical Research Centre, Harrow, she included the talents of medical, veterinary and basic science graduates to characterise the molecular identity of target antigens eliciting immune responses to transplants, tumours and autoantigens, and the immune response genes controlling those in vivo manifestations.
Peer review work included membership/chairmanship of MRC, BBSCR, WT, CRUK and ERC research funding committees, and of Scientific Advisory Boards to UK, French, German, Italian and South Korean research institutes.
She was elected a Fellow of the Academy of Medical Sciences in 1999, Fellow of the Royal Society in 2010 and awarded an OBE in 2000, honorary Fellowship of the RCVS in 2010 and an honorary DSc from Imperial in 2015.